Navigation path

HOME
Policy areas
Sectors
Who is in charge?
Competition and you
Cases
In this section:
Overview
What's new?
Official Journal
Legislation >
Cases
Statistics
Publications (Antitrust and Cartels)
Leniency
Whistleblower
Settlement
Compliance (Antitrust)
Practical information (Antitrust and Cartels)

Antitrust/Cartels

Antitrust/Cartel Cases

39612 Perindopril (Servier)

Companies: Biogaran / Krka Tovarna Zdravil / Laboratoires Servier / Lupin / Mylan / NICHE GENERICS (UK) / Servier SAS / Teva (UK) Limited / Teva Pharmaceuticals Europe B.V. / Unichem Laboratories
Economic Activity: C.21.2 - Manufacture of pharmaceutical preparations
Events:
Date Document Type Document
09.07.2014 Prohibition Decision (Art. 101 & 102 Ex 81 & 82) fr pdf  Published on 17.05.2017
en pdf  Published on 17.05.2017
09.07.2014 Provisional version of the decision en pdf  Published on 30.09.2016
fr pdf  Published on 30.09.2016
09.07.2014 Press Release Antitrust: Commission fines Servier and five generic companies for curbing entry of cheaper versions of cardiovascular medicine:
en
09.07.2014 No Public Version available, published on 10/07/2014 en pdf
30.07.2012 Press Release Antitrust: Commission sends Statement of Objections on perindopril to Servier and others:
en
23.07.2010 Article 20(4) Decision on LPP en pdf
02.07.2009 Opening of Proceedings en pdf
These publications are for information purposes only and should not be considered as an official publication

New Search

Help on how to use the case search tool